Stockreport

Beam Therapeutics (BEAM) Is Up 20.6% After Positive Gene-Editing Data And New Credit Facility - Has The Bull Case Changed? [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF deficiency, while also securing a US$500 million credit facility from Sixth Street to support an anticipated commercial launch. Amid these clinical and financing miles [Read more]